Hiroyoshi Ariga Selected Research

UCP0054278

1/2017	Effects of a DJ-1-Binding Compound on Spatial Learning and Memory Impairment in a Mouse Model of Alzheimer's Disease.
1/2011	Protection against dopaminergic neurodegeneration in Parkinson's disease-model animals by a modulator of the oxidized form of DJ-1, a wild-type of familial Parkinson's disease-linked PARK7.
3/2009	Protection against oxidative stress-induced neurodegeneration by a modulator for DJ-1, the wild-type of familial Parkinson's disease-linked PARK7.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Hiroyoshi Ariga Research Topics

Disease

27	Parkinson Disease (Parkinson's Disease) 03/2017 - 08/2003
14	Neoplasms (Cancer) 03/2017 - 09/2002
4	Neurodegenerative Diseases (Neurodegenerative Disease) 01/2017 - 09/2013
4	Brain Ischemia (Cerebral Ischemia) 01/2017 - 03/2008
3	Neuroblastoma 04/2017 - 02/2004
3	Retinitis Pigmentosa (Pigmentary Retinopathy) 01/2015 - 11/2004
3	Neoplasm Metastasis (Metastasis) 07/2004 - 09/2002
3	Infertility (Sterility) 04/2004 - 07/2002
3	Melanoma (Melanoma, Malignant) 11/2002 - 03/2002
2	Carcinogenesis 01/2015 - 04/2012
2	Huntington Disease (Huntington's Disease) 01/2014 - 07/2013
2	Stroke (Strokes) 07/2011 - 07/2008
2	Infarction (Infarctions) 01/2009 - 03/2008
1	Alzheimer Disease (Alzheimer's Disease) 03/2017
1	Body Weight (Weight, Body) 01/2016
1	Obesity 01/2016
1	Breast Neoplasms (Breast Cancer) 07/2015
1	Atrophy 01/2015
1	Type 2 Diabetes Mellitus (MODY) 01/2015
1	Hypertension (High Blood Pressure) 10/2014
1	Dementia (Dementias) 07/2014
1	Wounds and Injuries (Trauma) 01/2014
1	Stomach Neoplasms (Stomach Cancer) 04/2012
1	Lymphoma (Lymphomas) 01/2012
1	Leukemia 01/2012
1	Mitochondrial Diseases (Mitochondrial Disease) 01/2012
1	Ischemia 03/2009
1	Prostatic Neoplasms (Prostate Cancer) 02/2009
1	Middle Cerebral Artery Infarction (Middle Cerebral Artery Syndrome) 01/2009
1	Hypoxia (Hypoxemia) 08/2008
1	Reperfusion Injury 03/2008
1	Polyneuropathies (Polyneuropathy) 06/2007
1	Weight Loss (Weight Reduction) 06/2007
1	Tauopathies 06/2007

Drug/Important Bio-Agent (IBA)

24	Proteins (Proteins, Gene)FDA Link 03/2017 - 07/2002
7	AntioxidantsIBA 01/2017 - 07/2008
6	Dopamine (Intropin)FDA LinkGeneric 03/2015 - 10/2009
4	asparaginylendopeptidase (legumain)IBA 03/2017 - 01/2013
4	Neuroprotective AgentsIBA 07/2011 - 03/2008
3	Protein Deglycase DJ-1IBA 04/2017 - 01/2009
3	UCP0054278IBA 01/2017 - 03/2009
3	Carrier Proteins (Binding Protein)IBA 01/2015 - 01/2012
3	Molecular Chaperones (Chaperone, Molecular)IBA 01/2014 - 03/2008
3	Reactive Oxygen Species (Oxygen Radicals)IBA 12/2012 - 11/2005
3	tenascin XIBA 07/2004 - 09/2002
2	Androgen Receptors (Androgen Receptor)IBA 03/2017 - 11/2015
2	Transcription Factors (Transcription Factor)IBA 03/2017 - 11/2015
2	Biomarkers (Surrogate Marker)IBA 01/2017 - 07/2015
2	prefoldinIBA 01/2014 - 09/2013
2	triphenyltetrazoliumIBA 01/2009 - 03/2008
2	Messenger RNA (mRNA)IBA 09/2004 - 12/2003
2	Hydrogen Peroxide (Hydroperoxide)FDA LinkGeneric 07/2004 - 02/2004
2	Matrix Metalloproteinases (MMPs)IBA 07/2004 - 11/2002
2	Oncogene Proteins (Oncogene Protein)IBA 12/2003 - 07/2002
2	OrnidazoleIBA 12/2003 - 07/2002
1	Superoxides (Superoxide)IBA 04/2017
1	ParaquatIBA 04/2017
1	DiquatIBA 04/2017
1	AcidsIBA 03/2017
1	Pharmaceutical PreparationsIBA 01/2017
1	Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA 01/2016
1	GlucosidasesIBA 01/2016
1	Blood Glucose (Blood Sugar)IBA 01/2016
1	Hypoglycemic Agents (Hypoglycemics)IBA 09/2015
1	Protein Isoforms (Isoforms)IBA 07/2015
1	1- Methyl- 4- phenyl- 1,2,3,6- tetrahydropyridine (MPTP)IBA 03/2015
1	Insulin (Novolin)FDA Link 01/2015
1	CytokinesIBA 01/2015
1	Streptozocin (Streptozotocin)FDA Link 01/2015
1	Cysteine (L-Cysteine)FDA Link 07/2014
1	Monoclonal AntibodiesIBA 07/2014
1	neuromelaninIBA 07/2014
1	Peptides (Polypeptides)IBA 01/2014
1	mortalinIBA 01/2014
1	Heat-Shock Proteins (Heat-Shock Protein)IBA 01/2014
1	Cysteine Proteases (Cysteine Protease)IBA 08/2013
1	polyglutamineIBA 07/2013
1	Poly(ADP-ribose) Polymerase InhibitorsIBA 04/2012
1	Poly (ADP-Ribose) Polymerase-1IBA 04/2012
1	Indicators and Reagents (Reagents)IBA 07/2011
1	Pramipexole (Mirapex)FDA LinkGeneric 12/2009
1	UCP0045037IBA 11/2009
1	Carboxy-LyasesIBA 10/2009
1	Tyrosine (L-Tyrosine)FDA Link 10/2009
1	EnzymesIBA 10/2009
1	Tyrosine 3-Monooxygenase (Tyrosine Hydroxylase)IBA 10/2009
1	Insulin-Like Growth Factor Binding Protein 2IBA 02/2009
1	Histone Deacetylase 1IBA 08/2008
1	ElementsIBA 08/2008
1	ChromatinIBA 08/2008
1	PQQ Cofactor (Pyrroloquinoline Quinone)IBA 07/2008
1	Glutathione Transferase (Glutathione S-Transferase)IBA 03/2008
1	Peptide Hydrolases (Proteases)FDA Link 06/2007
1	RotenoneIBA 06/2007
1	Prealbumin (Transthyretin)IBA 06/2007
1	Small Nuclear Ribonucleoproteins (snRNP)IBA 01/2005
1	RNA Splicing FactorsIBA 11/2004

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 04/2012
1	Cell- and Tissue-Based Therapy (Cell Therapy) 07/2011
1	Therapeutics 07/2011